BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17064985)

  • 1. Extramedullary sites of leukemia relapse after transplant.
    Cunningham I
    Leuk Lymphoma; 2006 Sep; 47(9):1754-67. PubMed ID: 17064985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
    Ocheni S; Iwanski GB; Schafhausen P; Zander AR; Ayuk F; Klyuchnikov E; Zabelina T; Fiedler W; Schnittger S; Hochhaus A; Brümmendorf TH; Kröger N; Bacher U
    Leuk Lymphoma; 2009 Apr; 50(4):551-8. PubMed ID: 19373652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.
    Ge L; Ye F; Mao X; Chen J; Sun A; Zhu X; Qiu H; Jin Z; Miao M; Fu C; Ma X; Chen F; Xue S; Ruan C; Wu D; Tang X
    Biol Blood Marrow Transplant; 2014 Jul; 20(7):1040-7. PubMed ID: 24704575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
    Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
    Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
    Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation.
    Au WY; Lie AK; Liang R; Kwong YL
    Bone Marrow Transplant; 1999 Nov; 24(10):1137-40. PubMed ID: 10578164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18 FDG-PET/CT: 21st century approach to leukemic tumors in 124 cases.
    Cunningham I; Kohno B
    Am J Hematol; 2016 Jun; 91(4):379-84. PubMed ID: 26718745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute monoblastic leukemia that switched lineage at relapse to acute lymphoblastic leukemia: a case report.
    Inoue A; Kawakami C; Takitani K; Ikemoto T; Tamai H
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):e258-60. PubMed ID: 22217491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated testicular relapse after bone marrow transplant with total body irradiation and testicular boost in acute lymphoblastic leukemia.
    Li CK; Shing MM; Chik KW; Kwan WH; Lai DH; Leung TF; Yuen PM
    Bone Marrow Transplant; 1998 Aug; 22(4):397-9. PubMed ID: 9722077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
    Schlenk RF; Hartmann F; Hensel M; Jung W; Weber-Nordt R; Gabler A; Haas R; Ho AD; Trümper L; Döhner H
    Leukemia; 2002 Apr; 16(4):581-6. PubMed ID: 11960336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
    Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
    Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia.
    Moskop A; Pommert L; Thakrar P; Talano J; Phelan R
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28739. PubMed ID: 33009894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.
    Ponce DM; Hilden P; Devlin SM; Maloy M; Lubin M; Castro-Malaspina H; Dahi P; Hsu K; Jakubowski AA; Kernan NA; Koehne G; O'Reilly RJ; Papadopoulos EB; Perales MA; Sauter C; Scaradavou A; Tamari R; van den Brink MR; Young JW; Giralt S; Barker JN
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1985-93. PubMed ID: 26238810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
    Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
    HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
    Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.
    Shem-Tov N; Saraceni F; Danylesko I; Shouval R; Yerushalmi R; Nagler A; Shimoni A
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1087-1094. PubMed ID: 28396161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical review of breast involvement in acute leukemia.
    Cunningham I
    Leuk Lymphoma; 2006 Dec; 47(12):2517-26. PubMed ID: 17169796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
    Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
    J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.